HHC (hexahydrocannabinol) is made by adding hydrogen atoms to THC or CBD through a chemical process called catalytic hydrogenation. While HHC exists naturally in trace amounts in the cannabis plant, those quantities are far too small to extract commercially. Virtually all HHC on the market is semi-synthetic, produced in a lab by saturating the double bonds in a cannabinoid molecule with hydrogen gas.
The Core Chemistry: Catalytic Hydrogenation
The reaction behind HHC production is conceptually simple. THC has a double bond in its molecular ring structure, and hydrogenation forces hydrogen atoms across that bond, “saturating” it. The result is a more chemically stable molecule: hexahydrocannabinol. This is the same type of reaction used to turn liquid vegetable oils into solid margarine, just applied to a cannabinoid instead of a fat.
The most common route starts with delta-9 THC, delta-8 THC, or delta-10 THC dissolved in ethanol. A metal catalyst is added to the solution, then hydrogen gas is introduced. The catalyst provides a surface where hydrogen molecules break apart and attach to the cannabinoid’s double bond. In many published procedures, the reaction runs at room temperature and atmospheric pressure, stirring overnight. Yields typically land between 80% and 92%.
Because most commercial HHC producers work within hemp-derived supply chains, many start with CBD instead of THC. CBD is first converted into a form of THC through acid-catalyzed cyclization, then that intermediate is hydrogenated into HHC. This two-step pathway allows manufacturers to use federally legal hemp-derived CBD as a starting material rather than marijuana-derived THC.
Catalysts That Drive the Reaction
Two catalysts dominate HHC synthesis. Palladium on carbon (Pd/C) is the most widely used, typically at 5% or 10% concentration by weight. It reliably converts THC into a mixture of HHC isomers with high yields. The second common option is platinum oxide, known as Adam’s catalyst. Both are precious metal catalysts that must be carefully filtered out of the final product.
The choice of catalyst matters beyond just efficiency because it changes the ratio of the two HHC isomers produced. When palladium on carbon is used to hydrogenate delta-9 THC, the resulting mixture contains the 9S and 9R forms of HHC in roughly a 3:7 ratio. Adam’s catalyst (platinum oxide) shifts that ratio further, producing approximately a 2:8 split favoring the 9R isomer. This distinction has real consequences for the potency of the final product.
Why the 9R Isomer Matters
Every batch of HHC contains two mirror-image forms of the molecule: (9R)-HHC and (9S)-HHC. They are not equally active. The 9R isomer binds to the brain’s CB1 receptor with a strength very close to delta-9 THC itself, with roughly 17 times more potency at CB1 than the 9S version. In functional assays measuring how strongly the molecule activates those receptors, 9R-HHC nearly matches THC’s activity.
The 9S isomer still binds to cannabinoid receptors, but it activates them much less effectively. A batch of HHC with a higher proportion of 9R will feel noticeably stronger than one dominated by 9S. This is one reason why HHC products vary so much in perceived potency from brand to brand. The catalyst, reaction conditions, and starting material all influence the final isomer ratio, and most product labels don’t specify which ratio you’re getting.
Purification and Post-Processing
The raw output of hydrogenation is not ready for consumption. It contains residual catalyst particles, unreacted starting material, solvent, and various byproducts. Purification typically involves several steps: filtering out the metal catalyst, evaporating the ethanol solvent, and then running the crude oil through vacuum distillation to isolate the HHC fraction from leftover THC, CBD, and other compounds.
Vacuum distillation works by lowering the air pressure inside a glass apparatus so that different compounds boil off at lower temperatures than they normally would. This prevents heat from degrading the cannabinoids. Operators collect specific temperature fractions to isolate relatively pure HHC distillate. Some manufacturers add a final chromatography step to separate the 9R and 9S isomers or to remove trace contaminants, though this adds significant cost.
Safety Risks in Production
HHC synthesis carries real hazards, both during manufacturing and in the final product. Hydrogen gas is extremely flammable and can be explosive when mixed with air. Professional labs use specialized hydrogenation reactors with pressure-rated vessels, spark-free environments, and gas detection systems. Attempting this reaction without proper equipment is genuinely dangerous.
The finished product also poses risks if purification is inadequate. Palladium and platinum are heavy metals, and residual catalyst left in the oil after poor filtration means the consumer inhales or ingests those metals. Reputable manufacturers test for residual metals, residual solvents, and leftover THC or other cannabinoids. Without independent third-party lab testing confirming the absence of these contaminants, there is no way to know whether an HHC product is clean.
Unlike pharmaceutical manufacturing, HHC production currently operates without standardized safety thresholds or mandatory testing in most jurisdictions. The quality gap between a well-equipped lab with analytical chemistry capabilities and a crude operation cutting corners is enormous, and the consumer bears that risk entirely.
Legal Complexity
HHC occupies a gray area in U.S. law. The 2018 Farm Bill legalized hemp and hemp derivatives containing less than 0.3% delta-9 THC, and many HHC producers argue their products qualify because they’re derived from hemp-derived CBD. However, the DEA has signaled that synthetically derived cannabinoids remain controlled substances regardless of the starting material, and the distinction between “semi-synthetic” and “naturally derived” is legally contested.
Several states have moved to explicitly ban HHC and other converted cannabinoids, while others have not addressed them at all. The legal landscape is fragmented and shifting. If you’re considering purchasing or producing HHC, the legality depends heavily on your specific state and on how regulators classify the conversion process, something that varies and could change with little notice.